CN Patent

CN106265499A — 一种复合磷酸氢钾注射液药物组合物

Assigned to Pharmaceutical Co Ltd Tianjin Jin Yao · Expires 2017-01-04 · 9y expired

What this patent protects

一种药物组合物，每1000ml中由作为活性成分的217‑218g磷酸二氢钾、319‑320g磷酸氢二钾和作为辅料的水组成，其特征是组合物中的氧含量在2mg/L以下。

USPTO Abstract

一种药物组合物，每1000ml中由作为活性成分的217‑218g磷酸二氢钾、319‑320g磷酸氢二钾和作为辅料的水组成，其特征是组合物中的氧含量在2mg/L以下。

Drugs covered by this patent

Clinimix E 2.75/5 Sulfite Free W/ Elect In Dextrose 5% W/ Calcium In Plastic Container (POTASSIUM PHOSPHATE, DIBASIC) · Pfizer

Patent Metadata

Patent number: CN106265499A
Jurisdiction: CN
Classification: —
Expires: 2017-01-04
Drug substance claim: No
Drug product claim: No
Assignee: Pharmaceutical Co Ltd Tianjin Jin Yao
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.